Altamira Therapeutics Ltd. (CYTOF): 6-K filed May 9, 2025

Form type

6-K

Filing date

May 9, 2025

Accession number

0001213900-25-041560

Filer

Altamira Therapeutics Ltd. (CIK 1601936)